The prospective, single-arm clinical study will involve up to 15 sites across the U.S. and include 130 patients.
The study will examine the possibility of removing the self-expanding stent after the treatment of malignant and benign strictures. The study will also serve as an evaluation of the device’s use in esophageal conditions, including leaks, perforations, fistulas and strictures.
More Articles on Gastroenterology:
The Changing Healthcare Environment & Gastroenterologists: Q&A With Dr. Edwin Levine
Norwalk Hospital Adds Dr. Summa S. Magge
FDA Advisory Committee Reviews Vedolizumab Safety Concerns
